Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncolytic virus therapy--foreword.
Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, Kanazumi N, Nomoto S, Sugimoto H, Nakao A. Kasuya H, et al. Among authors: nakao a. Curr Cancer Drug Targets. 2007 Mar;7(2):123-5. doi: 10.2174/156800907780058826. Curr Cancer Drug Targets. 2007. PMID: 17346102
Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.
Nakao A, Takeda S, Shimoyama S, Kasuya H, Kimata H, Teshigahara O, Sawaki M, Kikumori T, Kodera Y, Nagasaka T, Goshima F, Nishiyama Y, Imai T. Nakao A, et al. Curr Cancer Drug Targets. 2007 Mar;7(2):169-74. doi: 10.2174/156800907780058808. Curr Cancer Drug Targets. 2007. PMID: 17346108 Clinical Trial.
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer.
Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Shirota T, Yamada S, Fujii T, Sugimoto H, Shikano T, Nomoto S, Takeda S, Kodera Y, Nishiyama Y. Nakao A, et al. Cancer Gene Ther. 2011 Mar;18(3):167-75. doi: 10.1038/cgt.2010.65. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102422 Clinical Trial.
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.
Sahin TT, Kasuya H, Nomura N, Shikano T, Yamamura K, Gewen T, Kanzaki A, Fujii T, Sugae T, Imai T, Nomoto S, Takeda S, Sugimoto H, Kikumori T, Kodera Y, Nishiyama Y, Nakao A. Sahin TT, et al. Among authors: nakao a. Cancer Gene Ther. 2012 Apr;19(4):229-37. doi: 10.1038/cgt.2011.80. Epub 2011 Dec 23. Cancer Gene Ther. 2012. PMID: 22193629
Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes.
Kanzaki A, Kasuya H, Yamamura K, Sahin TT, Nomura N, Shikano T, Shirota T, Tan G, Fukuda S, Misawa M, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Kodera Y, Nakao A. Kanzaki A, et al. Among authors: nakao a. Cancer Gene Ther. 2012 Apr;19(4):292-8. doi: 10.1038/cgt.2011.91. Epub 2012 Jan 27. Cancer Gene Ther. 2012. PMID: 22281756
Gene therapy for pancreatic cancer.
Kasuya H, Nomoto S, Kimata H, Harada A, Takeda S, Hayashi S, Nakao A. Kasuya H, et al. Among authors: nakao a. Hepatogastroenterology. 2001 Jul-Aug;48(40):957-61. Hepatogastroenterology. 2001. PMID: 11490848 Review.
1,444 results